Spago Nanomedical: Phase IIa trial with SpagoPix in endometriosis - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Spago Nanomedical: Phase IIa trial with SpagoPix in endometriosis - Redeye

{newsItem.title}

Redeye comments on Spago resolving to conclude SPAGOPIX-01 and starting a phase IIa trial with SpagoPix/SN132D in endometriosis. We previously viewed a potential SpagoPix deal in 2023e as a significant catalyst and source of non-dilutive funding. However, our suspicion that SPAGOPIX-01 data might not suffice to strike a deal seemingly turned out correct, and we judge a SpagoPix deal is now likely in 2024e. We adjust our estimates and lower our valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/867829/spago-nanomedical-phase-iia-trial-with-spagopix-in-endometriosis?utm_source=finwire&utm_medium=RSS

Nyheter om Spago Nanomedical

Läses av andra just nu

Om aktien Spago Nanomedical

Senaste nytt